EATG » R&D

R&D

WHO studies on local pharma production provide key contrasts between China, India

Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local…

WHO, stakeholders take ‘first step’ on fair pricing for medicines

The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible…

G20: Can the world’s richest economies innovate for global health?

The term “neglected tropical diseases” is on the way out. Instead, global health experts are beginning to favor the less geographically-restricted “neglected poverty-related diseases,” which reflects not only the borderlessness…

TB and antimicrobial resistance – new models of R&D needed

An editorial published in the Bulletin of the World Health Organization reflects on the need for new models of research and development (R&D) for TB and antimicrobial resistance and describes…

EASL launches major new funding initiative

The EASL International Liver Foundation will drive funding to a wide range of initiatives in Research & Development, Education and Public Awareness. In a keynote speech, at the International Liver…

Demands of disease drive vaccine science

Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists Vaccine research has a long history, dating back to Edward Jenner’s first inoculation against…

Report finds wide gap in pharma companies’ profits and spending on R&D

A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines…

TB Alliance sublicenses promising TB drug from the Medicines Patent Pool

Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer. NEW YORK and GENEVA, 24 March 2017 — On World Tuberculosis Day,…

WHO Advisory Group report on Fair Pricing Forum released

The report from a meeting of a World Health Organization informal advisory group on challenges of medicines pricing and organising a Fair Pricing Forum this spring has been made public.…

TB community demands WHO to include #TBontheList!

The Stop TB Partnership delivered the letter to WHO requesting inclusion of Mycobacterium tuberculosis in the WHO's Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of…